Location: | Oxford |
---|---|
Salary: | £34,982 to £40,855 per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 17th June 2025 |
---|---|
Closes: | 15th July 2025 |
Job Ref: | 180361 |
This is an exciting and unique opportunity for a talented, curious scientist who wants to make new scientific discoveries in T cell immunology and immunotherapeutics. You will work in the Vyas Laboratory on discovering new peptide-HLA-II (pHLA-II) antigens and their cognate T cell receptors (TCRs), interrogating their function, molecular and biophysical features and conduct proof of concept work to establish their utility as immunotherapeutics.
You will be part of a multi-disciplinary team that includes immunologists with molecular, cellular, biochemical and structural expertise. You will work with patient samples and dissect alloreactive immune responses, repurposing them to make novel TCR-T cell and soluble bispecific T cell engager therapeutics.
You will have an undergraduate degree in a relevant biological science, together with relevant laboratory and computational experience (flow cytometry, cell culture, molecular sub-cloning and analysis of next generation sequence data). Experience in coding and using computational pipelines with specialist knowledge in T cell immunology and immunology of cancer and cancer immunotherapeutics will be essential.
The role could suit an applicant wanting to go onto do a PhD or wanting to explore working in the Vyas Laboratory on a longer-term basis.
The post is available fixed-term for 12 months, funded by Yellowstone Bioscience.
Applications for this vacancy are to be made online. You will be required to upload a CV and supporting statement as part of your online application.
The closing date for this position is 12:00 noon on Monday 15 July 2025. Interviews will be held w/c 28 July 2025.
Type / Role:
Subject Area(s):
Location(s):